Non-Hodgkin Lymphoma Program
If your child has been diagnosed with non-Hodgkin lymphoma, you probably have lots of questions about treatment. If your child has relapsed or hard-to-treat non-Hodgkin lymphoma, we provide direct access to the newest clinical trials and advanced therapies.
Here at Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC), your child will receive care from many of the world’s most experienced pediatric oncologists at Dana-Farber Cancer Institute and internationally recognized pediatric subspecialists at Children’s Hospital Boston.
The non-Hodgkin Lymphoma Program is a special part of DF/CHCC.
- All members of our team, which includes pediatric oncologists, radiation oncologists, surgeons, interventional and diagnostic radiologists and hematopathologists, have specific expertise in pediatric lymphomas.
- We offer comprehensive diagnosis, treatment, consultation services for children and adolescents.
- We provide access to multiple clinical trials investigating new treatment approaches, as well as advanced therapies like stem cell transplantation.
- Our center offers a long-term care program specially designed for survivors of childhood cancer.
Did you know? Lymphoma
Lymphoma, which includes Hodgkin and non-Hodgkin disease, is the third most common cancer in children after leukemia and cancers of the brain and nervous system.
Did you know? Patient and family-centered care
We adhere to a patient and family-centered care model. Since 1999, our Pediatric Patient and Family Council has been instrumental in guiding our decision-making, from patient safety efforts to the design of our clinical facilities to quality improvement initiatives.